Defining the Next Generation of Digital Biomarkers

Name: Defining the Next Generation of Digital Biomarkers
Start: 2026-06-16T08:30:00Z
End: 2026-06-16T10:00:00.000Z
Location: Amsterdam

*HLTH Europe 2026 - TICKET REQUIRED | Applications approved by the Sponsor

About this Meeting

Co-hosted by HLTH and Roche, this session builds on insights from a virtual roundtable on the evolution of digital biomarkers toward digital phenotyping, and the new opportunities this shift is creating, particularly in metabolic diseases.

More details to come.

By applying to this event, you agree to our Terms and Privacy Notice.

How Clinical Data is Evolving from Documentation to Decision Intelligence

Patient-Centricity in the Age of AI

VIP Pass: Connecting leaders to transform healthcare!

Executive Masterclass 2 - Direct to Patient, Redefined: Pharma’s Next Commercial Frontier

The Empty Chair: A Dinner on the Future of Patient Acquisition

Rethinking Employer Health Strategies: Balancing Cost, Care, and Culture

What does “Direct-to-Patient” engagement realistically mean in Europe - and what needs to change for it to work?

In the Loop, On the Loop, Off the Loop: Radiology's Next Decade of Agents and Oversight

Why Don’t Healthcare Companies Say What They Do?

Defining the Next Generation of Digital Biomarkers

About this Meeting

Featured:

How Clinical Data is Evolving from Documentation to Decision Intelligence

Sponsored by:

Patient-Centricity in the Age of AI

Sponsored by:

Featured:

VIP Pass: Connecting leaders to transform healthcare!

Executive Masterclass 2 - Direct to Patient, Redefined: Pharma’s Next Commercial Frontier

Featured:

The Empty Chair: A Dinner on the Future of Patient Acquisition

Sponsored by:

Rethinking Employer Health Strategies: Balancing Cost, Care, and Culture

Sponsored by:

Featured:

What does “Direct-to-Patient” engagement realistically mean in Europe - and what needs to change for it to work?

Sponsored by:

Featured:

In the Loop, On the Loop, Off the Loop: Radiology's Next Decade of Agents and Oversight

Why Don’t Healthcare Companies Say What They Do?

Defining the Next Generation of Digital Biomarkers

About this Meeting